LTGO

Conviction 0Scan · Tue, Aug 18, 2026

LTGO$19.30-0.97%

ResistanceSupportVol 14Insider buy

Aug 7Aug 10Aug 11Aug 13Aug 14Aug 17

Latigo Biotherapeutics, Inc.Pharmaceutical Preparations

Price19.30

Change-0.97%

Gap+0.00%

Rel volume0.21×

Avg volume728.25K

Avg $ vol13.51M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high20.06

52w low18.25

From 52w high-3.79%

Above 52w low+5.75%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)19.39

vs AVWAP high-0.48%

AVWAP (52w low)18.95

vs AVWAP low+1.87%

OBV trend—

Chaikin MF (20)—

Today vs 20d0.21×

Avg vol (14d)—

Avg vol (20d)728.25K

Avg $ vol (20d)13.51M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank53.9

1 week+3.99%

1 month—

3 months—

6 months—

1 year—

YTD+5.75%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank53.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in LTGO

All disclosures →

No recent disclosed trades by Congress in LTGO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LTGO · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Sanofi 10% owner · Common Stock · 2026-08-10	Convert	177.98K	—	2026-08-10	2026-08-12
Sanofi 10% owner · Series B Preferred Stock · 2026-08-10	Convert	494.8K	—	2026-08-10	2026-08-12
Sanofi 10% owner · Convertible Promissory Note · 2026-08-10	Convert	177.98K	—	2026-08-10	2026-08-12
5AM Ventures VI, L.P. 10% owner · Common Stock · 2026-08-10	Convert	2.35M	—	2026-08-10	2026-08-12
5AM Ventures VI, L.P. 10% owner · Series A Preferred Stock · 2026-08-10	Convert	3.15M	—	2026-08-10	2026-08-12
5AM Ventures VI, L.P. 10% owner · Series A-2 Preferred Stock · 2026-08-10	Convert	1.82M	—	2026-08-10	2026-08-12
5AM Ventures VI, L.P. 10% owner · Series A-2 Preferred Stock · 2026-08-10	Convert	866.02K	—	2026-08-10	2026-08-12
5AM Ventures VI, L.P. 10% owner · Common Stock · 2026-08-10	Convert	4.98M	—	2026-08-10	2026-08-12
5AM Ventures VI, L.P. 10% owner · Series B Preferred Stock · 2026-08-10	Convert	1.48M	—	2026-08-10	2026-08-12
Sanofi 10% owner · Common Stock · 2026-08-10	Convert	494.8K	—	2026-08-10	2026-08-12

SEC filings

EDGAR filings in LTGO · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.